Aclaris Therapeutics, Inc. — Director's Dealing 2016

Apr 21, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aclaris Therapeutics, Inc. (ACRS)
CIK: 0001557746
Period of Report: 2016-04-19

Reporting Person: FMR LLC (10% Owner, See Remark 1)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-19	Common Stock	J	1014381	—	Disposed	2789898	Indirect

Footnotes

F1: F-Prime Capital Partners Healthcare Fund III LP made a pro-rata distribution to its partners, without payment of consideration, of 2,864,870 shares of Aclaris Therapeutics Inc. previously reported by FMR LLC. F-Prime Capital Partners Healthcare Fund III LP distributed 1,848,054 shares to Impresa Fund III Limited Partnership, 21,600 shares to F-Prime Capital Partners Healthcare Advisors Fund III LP (FPCPHA) and 995,216 shares to a recipient whose shares are not subject to reporting by the undersigned (an Other Recipient). FPCPHA made a pro-rata distribution to its partners, without payment of consideration, of 2,435 shares to F-Prime Inc, a wholly-owned subsidiary of FMR LLC, and 19,165 shares to Other Recipients.